Engineering Extracellular Vesicles for Osteoarthritis Treatment: From Therapeutic Strategies-to-Clinical Translation
Announcing a new article publication for BIO Integration journal. Extracellular vesicles (EVs) are membrane-bound nanoparticles secreted by cells and have emerged as promising therapeutic agents for osteoarthritis (OA). These vesicles exhibit high biocompatibility and the intrinsic ability to traverse physiologic barriers, delivering bioactive molecular cargo to recipient cells to exert regulatory effects. To enhance therapeutic efficacy, EVs can be bioengineered to improve biological activity and targeting capacity toward specific cells or tissues. Strategies for EV engineering primarily involve modifications to cargo, membranes, or the pretreatment of parental cells. In recent years advances in EV engineering have led to growing interest in the application of engineered EVs for OA treatment, offering new possibilities for clinical translation. This review summarizes the fundamental characteristics of EVs and examine the factors limiting the current therapeutic efficacy in OA. An overview of existing engineering strategies and a discussion of the therapeutic applications of engineered EVs in OA models is also provided. Finally the remaining challenges and future directions necessary to advance EV-based therapies toward clinical use in OA are outlined.
Read full open access article at https://www.scienceopen.com/hosted-document?doi=10.15212/bioi-2025-0177
# # # # # #
BIO Integration is fully open access journal which will allow for the rapid dissemination of multidisciplinary views driving the progress of modern medicine.
As part of its mandate to help bring interesting work and knowledge from around the world to a wider audience, BIOI will actively support authors through open access publishing and through waiving author fees in its first years. Also, publication support for authors whose first language is not English will be offered in areas such as manuscript development, English language editing and artwork assistance.
Please visit www.bio-integration.org to learn more about the journal.
Editorial Board: https://bio-integration.org/editorial-board/
BIOI is available on the ScienceOpen platform (https://www.scienceopen.com/search#collection/55f45bac-fd64-431c-9fe7-50fd6a7f8781).
Submissions may be made using ScholarOne (https://mc04.manuscriptcentral.com/bioi).
There are no author submission or article processing fees.
Follow BIOI on Twitter @JournalBio; Facebook (https://www.facebook.com/BIO-Integration-Journal-108140854107716/) and LinkedIn (https://www.linkedin.com/company/bio-integration-journal/).
ISSN 2712-0074
eISSN 2712-0082
Jiashuo Liu, Lei Luo and Kai Feng et al. Engineering Extracellular Vesicles for Osteoarthritis Treatment: From Therapeutic Strategies-to-Clinical Translation. BIOI. 2026. Vol. 7(1). DOI: 10.15212/bioi-2025-0177
